Skip to main content
editorial
. 2020 Oct 28;10(1):1–5. doi: 10.1007/s40120-020-00222-3
Lennox–Gastaut syndrome is a devastating epilepsy syndrome which is characteristically refractory to antiseizure medications.
Despite drug resistance, antiseizure medications are the mainstay of treatment.
The study looks at the perspective of a parent and a physician regarding treatment of this syndrome.
Success with medicine can be achieved, even with refractory epilepsy syndromes, and will continue to be optimized as more focused research and targeted treatments are developed.